Not provided
Not provided
Not provided
Not provided
funding
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| AT&T and Vital Tech | UNKNOWN |
Not provided
Not provided
Not provided
Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital Tech, on blood pressure control and primary care engagement.
Emergency Department (ED) clinicians encounter patients with asymptomatic hypertension (HTN) on a daily basis but usually fail to intervene. This pilot study will determine the utility of a novel intervention: Telehealth Referral to Improve Outcomes (TRIO), a conceptually driven information technology tool focused on patients who are asymptomatic and hypertensive upon ED discharge. It is designed to successfully link them to a primary care provider (PCP) after ED discharge to improve blood pressure (BP) control. 48 adult ED patients who have asymptomatic HTN (BP >/= 140/90 mmg and \
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TRIO PLUS tablet and nurse at day 3 | Experimental | Virtual nurse encounter at 3 days |
|
| TRIO PLUS Tablet and nurse at day 3 and 7 | Experimental | Virtual nurse encounter at 3 days and 7 days |
|
| TRIO PLUS Group | Placebo Comparator | No encounter |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood pressure cuff PLUS tablet | Device | all arms |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment rate | recruitment rate of patients enrolled in TRIO at 6-months. | 6 months |
| Recruitment rate | recruitment rate of patients enrolled in TRIO at 12-months. | 12 months |
| Retention rate | retention rate of patients enrolled in TRIO at 6-months. | 6 months |
| Retention rate | retention rate of patients enrolled in TRIO at 12-months. | 12 months |
| Attrition rate | attrition rate of patients enrolled in TRIO at 6-months. | 6 months |
| Attrition rate | attrition rate of patients enrolled in TRIO at 12-months. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Blood pressure | 6 months | |
| Blood pressure | 12 months | |
| Number of participant who had follow up care |
Not provided
Inclusion Criteria:
Age ≥ 18 years
At least two* high blood pressure readings during ED visit
Systolic (top #) ≥140, ≤180 AND/OR
Diastolic (bottom #) ≥ 90, ≤120
*Second blood pressure may be confirmed when approaching the patient. Before approaching, check exclusions first.
Exclusion Criteria:
symptomatic hypertension
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kimberly Souffront, PhD, APRN | Icahn School of Medicine at Mount Sinai | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Sinai Hospital Center Emergency Dept | New York | New York | 10029 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 17, 2024 | Aug 12, 2024 | 3 | ||
| Aug 16, 2024 |
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D004630 | Emergencies |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Both participant and investigator will be blinded on the study assignment group.
|
| Telehealth Consult | Other | Telehealth consult with an RN |
|
Primary Care Engagement to be defined as having follow up care (yes/no) at 6 months
| 6 months |
| Number of participant who had follow up care | Primary Care Engagement to be defined as having follow up care (yes/no) at 12 months | 12 months |
| Sep 9, 2024 |
| 4 |
| D013568 |
| Pathological Conditions, Signs and Symptoms |